지혈제 및 조직 봉합제 시장 : 제품 유형별, 용도별, 최종 사용자별 및 지역별

Hemostasis And Tissue Sealing Agents Market is estimated to be valued at USD 4.00 Bn in 2026 and is expected to reach USD 5.93 Bn by 2033, growing at a compound annual growth rate (CAGR) of 5.8% from 2026 to 2033.

Hemostasis and tissue sealing agents play a vital role in surgical procedures by enabling surgeons to control bleeding and seal tissues. They work by forming a protective layer over incisions and wounds to accelerate the body's natural clotting process. Some commonly used hemostasis and tissue sealing products include sealants, glues, fibrin patches, collagen-based solutions, and absorbable gels. The global hemostasis and tissue sealing agents market has been growing in response to the rising need for more effective hemorrhage management solutions across various surgical specialties like cardiovascular, orthopedic, neurovascular, and general surgeries.

Market Dynamics:

The key drivers fueling the hemostasis and tissue sealing agents market include rapid growth in surgical procedures globally, increasing preference for minimally invasive surgeries, rising healthcare spending in emerging nations, and technological advancements leading to improved product portfolios. However, factors such as product recalls owing to safety concerns, stringent regulatory norms, and price pressures from large generic manufacturers pose significant challenges. On the positive side, ongoing research and development towards developing next-gen hemostats and sealants with superior efficacy is opening new avenues for market players. Growing applications of tissue adhesives in traumatic injury repair also present attractive opportunities for growth of hemostasis and tissue sealing agents market.

Key Features of the Study:

• It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global hemostasis and tissue sealing agents market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies
• The key companies covered as a part of this study include Ethicon (a subsidiary of Johnson & Johnson), Baxter International, CryoLife, B. Braun Melsungen AG, Covidien (now part of Medtronic), Integra LifeSciences, Pfizer, BD, Teleflex and Arch Therapeutics
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global hemostasis and tissue sealing agents market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global hemostasis and tissue sealing agents market

Detailed Segmentation:

• By Product Type (Revenue, USD Bn, 2021 - 2033)
• Topical Hemostats & Adhesives
• Tissue Sealing Agents
• By Application (Revenue, USD Bn, 2021 - 2033)
• Cardiovascular Surgery
• Orthopedic Surgery
• General Surgery
• Neurosurgery
• Others
• By End User (Revenue, USD Bn, 2021 - 2033)
• Hospitals
• Ambulatory Surgical Centers
• Home Care Settings
• Regional Insights (Revenue, USD Bn, 2021 - 2033)
• North America
  • U.S.
  • Canada
• Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
• Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
• Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
• Africa
  • South Africa
  • North Africa
  • Central Africa
• Company Profiles:
• Ethicon (a subsidiary of Johnson & Johnson)
• Baxter International
• CryoLife
• Braun Melsungen AG
• Covidien (now part of Medtronic)
• Integra LifeSciences
• Pfizer
• BD
• Teleflex
• Arch Therapeutics

Table of Contents:

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Global Hemostasis and Tissue Sealing Agents Market , By Product Type
  • Global Hemostasis and Tissue Sealing Agents Market , By Application
  • Global Hemostasis and Tissue Sealing Agents Market , By End User
  • Global Hemostasis and Tissue Sealing Agents Market , By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Opportunities
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario

4. Hemostasis and Tissue Sealing Agents Market, By Product Type, 2021 - 2033, (US$ Billion)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022 - 2033
  • Segment Trends
• Topical Hemostats & Adhesives
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)
• Tissue Sealing Agents
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)

5. Hemostasis and Tissue Sealing Agents Market, By Application, 2021 - 2033, (US$ Billion)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022 - 2033
  • Segment Trends
• Cardiovascular Surgery
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)
• Orthopedic Surgery
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)
• General Surgery
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)
• Neurosurgery
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)

6. Hemostasis and Tissue Sealing Agents Market, By End User, 2021 - 2033, (US$ Billion)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022 - 2033
  • Segment Trends
• Hospitals
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)
• Ambulatory Surgical Centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)
• Home Care Settings
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)

7. Hemostasis and Tissue Sealing Agents Market, By Region, 2021 - 2033, (US$ Billion)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022 - 2033
  • Segment Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Billion)
    • U.S.
    • Canada
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Billion)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Billion)
    • China
    • Japan
    • India
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Billion)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Billion)
    • GCC
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (US$ Billion)
    • North Africa
    • Central Africa
    • South Africa

8. Competitive Landscape

• Ethicon (a subsidiary of Johnson & Johnson)
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Baxter International
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• CryoLife
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• B.Braun Melsungen AG
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Covidien (now part of Medtronic)
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Integra LifeSciences
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Pfizer Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• BD
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Teleflex
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Arch Therapeutics
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies

9. Section

• Research Methodology
• About us